Exact Mass: 417.1477

Exact Mass Matches: 417.1477

Found 100 metabolites which its exact mass value is equals to given mass value 417.1477, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine amide

2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine amide

C20H23N3O7 (417.1536)


   

Gabexate mesylate

Gabexate mesylate

C17H27N3O7S (417.157)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants

   

N-Acetyl gemifloxacin

1-cyclopropyl-7-[(4E)-3-acetamido-4-(methoxyimino)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C19H20FN5O5 (417.1448)


N-Acetyl gemifloxacin is a metabolite of gemifloxacin. Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Oscient Pharmaceuticals has licensed the active ingredient from LG Life Sciences of Korea. (Wikipedia)

   

3'-Amino-3'-deoxythimidine glucuronide

(2S,3S,4S,5R)-4-{[3-amino-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}-3,5,6-trihydroxyoxane-2-carboxylic acid

C16H23N3O10 (417.1383)


3-Amino-3-deoxythimidine glucuronide is a metabolite of zidovudine. Zidovudine or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the successful treatment of HIV/AIDS infectiousness. It is a therapeutic analog of thymidine. AZT is the first U.S. government-approved treatment for HIV therapy, prescribed under the names Retrovir and Retrovis. (Wikipedia)

   
   

3-O-beta-D-glucopyranosylfagomine

(-)-3-O-beta-D-Glucopyranosylfagomine

C21H23NO8 (417.1424)


   
   

(5S,8S,9R)-8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexenyl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione|8-O-demethylpseurotin A|pseurotin F2

(5S,8S,9R)-8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexenyl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione|8-O-demethylpseurotin A|pseurotin F2

C21H23NO8 (417.1424)


   
   

Sorbicillacton A|sorbicillactone A

Sorbicillacton A|sorbicillactone A

C21H23NO8 (417.1424)


   
   
   
   
   
   
   

N-ethyl-2-pyrrolidinone substituted flavan-3-ols (three hydroxy groups on B-ring)

N-ethyl-2-pyrrolidinone substituted flavan-3-ols (three hydroxy groups on B-ring)

C21H23NO8 (417.1424)


   

C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

NCGC00380250-01_C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

C21H23NO8 (417.1424)


   

C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

NCGC00381007-01_C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

C21H23NO8 (417.1424)


   
   

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate])

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate])

C21H23NO8 (417.1424)


   

Lys-Tyr-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-3-(4-hydroxyphenyl)propanoic acid

C20H23N3O7 (417.1536)


   

3-N-FMOC-3-(3-METHOXYPHENYL)PROPIONIC ACID

3-N-FMOC-3-(3-METHOXYPHENYL)PROPIONIC ACID

C25H23NO5 (417.1576)


   

4-(DIFLUOROMETHYL)-1-FLUOROBENZENE

4-(DIFLUOROMETHYL)-1-FLUOROBENZENE

C25H23NO5 (417.1576)


   

N-Fmoc-(2S,3S)-3-Amino-2-hydroxy-4-phenyl-butyric acid

N-Fmoc-(2S,3S)-3-Amino-2-hydroxy-4-phenyl-butyric acid

C25H23NO5 (417.1576)


   

Fmoc-D-phe(4-OCH3)-OH

Fmoc-D-phe(4-OCH3)-OH

C25H23NO5 (417.1576)


   

Fmoc-(R)-3-Amino-3-(2-methoxyphenyl)-propionic acid

Fmoc-(R)-3-Amino-3-(2-methoxyphenyl)-propionic acid

C25H23NO5 (417.1576)


   

fmoc-(r)-3-amino-3-(3-methoxy-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(3-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)


   

Fmoc-beta-(R)-4-methoxyphenylalanine

Fmoc-beta-(R)-4-methoxyphenylalanine

C25H23NO5 (417.1576)


   

Fmoc-Ser(Bzl)-OH

Fmoc-Ser(Bzl)-OH

C25H23NO5 (417.1576)


   

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside

C16H23N3O10 (417.1383)


   

Fmoc-4-Methoxy-L-phenylalanine

Fmoc-4-Methoxy-L-phenylalanine

C25H23NO5 (417.1576)


   

Fmoc-D-Ser(Bzl)-OH

Fmoc-D-Ser(Bzl)-OH

C25H23NO5 (417.1576)


   

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

C27H19N3O2 (417.1477)


   

Duloxetine Impurity A

Duloxetine Impurity A

C25H23NO3S (417.1399)


   

Fmoc-L-Ser-Obzl

Fmoc-L-Ser-Obzl

C25H23NO5 (417.1576)


   

fmoc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)


   

fmoc-(s)-3-amino-3-(3-methoxy-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(3-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)


   

4-(1-Methylethyl)-2-(tributylstannyl)-Thiazole

4-(1-Methylethyl)-2-(tributylstannyl)-Thiazole

C18H35NSSn (417.1512)


   

Mono-POC Methyl Tenofovir (Mixture of DiastereoMers)

Mono-POC Methyl Tenofovir (Mixture of DiastereoMers)

C15H24N5O7P (417.1413)


   

Chloroquine sulfate

chloroquine sulphate

C18H28ClN3O4S (417.1489)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Xaliproden hydrochloride

Xaliproden hydrochloride

C24H23ClF3N (417.1471)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent Xaliproden hydrochloride (SR57746A) is a potent, selective and orally active agonist of 5-HT1A receptor, shows a high affinity for 5-HT1A specific binding sites in the rat hippocampus (IC50=3 nM). Xaliproden hydrochloride is also a selective antagonist of dopamine D2 receptor, has moderate affinity (IC50=0.1-1 μM). Xaliproden hydrochloride exhibits anti-depression and anti-anxiety effects, and it may possess therapeutic potential for the research of neurodegenerative diseases[1][2][3].

   

Fmoc-HomoTyr-OH

Fmoc-HomoTyr-OH

C25H23NO5 (417.1576)


   

(S)-Fmoc-α-Me-Tyr-OH

(S)-Fmoc-α-Me-Tyr-OH

C25H23NO5 (417.1576)


   

Daidzein-D3-7-O-b-D-glucopyranoside

Daidzein-D3-7-O-b-D-glucopyranoside

C22H19O8D3 (417.1503)


   

GABEXATE MESILATE

GABEXATE MESILATE

C17H27N3O7S (417.157)


   

(S)- FMOC-2-METHOXYPHENYLALANINE

(S)- FMOC-2-METHOXYPHENYLALANINE

C25H23NO5 (417.1576)


   

Amonafide L-malate

Amonafide L-malate

C20H23N3O7 (417.1536)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

14-norpseurotin A

14-norpseurotin A

C21H23NO8 (417.1424)


An alkaloid that is the 14-nor derivative of pseurotin A. Isolated from Aspergillus sydowii, it exhibits antibacterial, antileishmanial and anticancer activities.

   

3-(4-morpholinyl)-4-(2-pyridinyl)-N-[3-(trifluoromethyl)phenyl]-1-pyrazolecarboxamide

3-(4-morpholinyl)-4-(2-pyridinyl)-N-[3-(trifluoromethyl)phenyl]-1-pyrazolecarboxamide

C20H18F3N5O2 (417.1413)


   

(1R,4R,6R,7R,11Z)-4-[(1R)-1-chloroethyl]-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

(1R,4R,6R,7R,11Z)-4-[(1R)-1-chloroethyl]-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H28ClNO7 (417.1554)


   

N6-Isopentenyl-Adenosine-5-Monophosphate

N6-Isopentenyl-Adenosine-5-Monophosphate

C15H24N5O7P (417.1413)


   

2-phenyl-N-(6-(piperazin-1-yl)pyridin-3-yl)-4-(trifluoromethyl)oxazole-5-carboxamide

2-phenyl-N-(6-(piperazin-1-yl)pyridin-3-yl)-4-(trifluoromethyl)oxazole-5-carboxamide

C20H18F3N5O2 (417.1413)


   

Nivaquine

Nivaquine

C18H28ClN3O4S (417.1489)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018501 - Antirheumatic Agents

   

N-[2-[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl]piperidin-1-yl]ethyl]methanesulfonamide

N-[2-[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl]piperidin-1-yl]ethyl]methanesulfonamide

C18H28ClN3O4S (417.1489)


   

Dimethyl 2-[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylfuran-3-carbonyl]amino]pentanedioate

Dimethyl 2-[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylfuran-3-carbonyl]amino]pentanedioate

C21H23NO8 (417.1424)


   

N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamide

N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamide

C21H24ClN3O4 (417.1455)


   

N-[(2S,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

N-[(2S,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

C21H21F2N3O4 (417.15)


   

N-[(2R,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2R,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

N-[(2R,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

N-[(2R,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

C21H21F2N3O4 (417.15)


   

N-[(2R,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2R,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

N-[(2S,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2S,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

(1R,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)


   

N-[(2S,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2S,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

N-[(2S,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2S,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

N-[(2R,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

N-[(2R,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)


   

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)


   

(1R,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)


   

(1S,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)


   

(1S,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)


   
   
   
   

deoxynivalenol 10-S-cysteine

deoxynivalenol 10-S-cysteine

C18H27NO8S (417.1457)


   

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-[2-(2-hydroxyethoxy)ethyl]pyrrolidine-2,3-dione

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-[2-(2-hydroxyethoxy)ethyl]pyrrolidine-2,3-dione

C21H23NO8 (417.1424)


   
   

3-Methoxy-2,6-dimethyl-(6R)-((2R)-2-methylbutyryloxy)-5-(4-nitrobenzoyloxy)-2,4-cyclohexadien-1-one

3-Methoxy-2,6-dimethyl-(6R)-((2R)-2-methylbutyryloxy)-5-(4-nitrobenzoyloxy)-2,4-cyclohexadien-1-one

C21H23NO8 (417.1424)


   

N-Acetyl gemifloxacin

N-Acetyl gemifloxacin

C19H20FN5O5 (417.1448)


   

3-Amino-3-deoxythimidine glucuronide

3-Amino-3-deoxythimidine glucuronide

C16H23N3O10 (417.1383)


   

desacetyldoronine

desacetyldoronine

C19H28ClNO7 (417.1554)


A pyrrolizine alkaloid that is produced by a hybrid species of Jacobaea.

   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(2e)-3-{[(3s,3ar,4z,7as)-7-hydroxy-4-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

(2e)-3-{[(3s,3ar,4z,7as)-7-hydroxy-4-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H23NO8 (417.1424)


   

3-{[7-hydroxy-4-(1-hydroxyhexa-2,4-dien-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

3-{[7-hydroxy-4-(1-hydroxyhexa-2,4-dien-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H23NO8 (417.1424)


   

8-benzoyl-2-(1,2-dihydroxypent-3-en-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxypent-3-en-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8ar)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8ar)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)


   

(1s,6s,7s)-4-(1-chloroethyl)-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

(1s,6s,7s)-4-(1-chloroethyl)-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H28ClNO7 (417.1554)


   

3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)